The chemically active component of Obsidan
Szám, L.; Schuller, A.
Orvosi Hetilap 113(2): 109
1972
ISSN/ISBN: 0030-6002 PMID: 5009531 Document Number: 49519
Document emailed within 1 workday
Related Documents
Viganò, G.; Zoja, C.; Corna, D.; Rossini, M.; Pusineri, F.; Garattini, S.; Remuzzi, G. 1990: 17 beta-estradiol is the most active component of the conjugated estrogen mixture active on uremic bleeding by a receptor mechanism Journal of Pharmacology and Experimental Therapeutics 252(1): 344-348Humphries, H.; Osman, F.; Knight, L.; Abdool Karim, Q. 2019: Who is sexually active? Using a multi-component sexual activity profile (MSAP) to explore, identify and describe sexually-active high-school students in rural KwaZulu-Natal, South Africa Bmc Public Health 19(1): 317
Budker, V.G.; Grineva, N.I.; Karpova, G.G.; Kobets, N.D.; Maev, S.P. 1977: Affinity modification of Escherichia coli ribosomes in the region of the mRNA-binding center by a heptauridylate analog bearing a chemically active group at the 3' end Molekuliarnaia Biologiia 12(3): 539-545
Vepreková 1978: Approximative molecular weight of the active component in toxoplasmin Folia Parasitologica 25(3): 273-275
Nakano, M. 1974: The adjuvant effect of bacterial endotoxin: its active component and action mechanism Nihon Rinsho. Japanese Journal of Clinical Medicine 32(8): 2715-2722
Randhawa, M.A.; Alghamdi, M.S.; Maulik, S.K. 2013: The effect of thymoquinone, an active component of Nigella sativa, on isoproterenol induced myocardial injury Pakistan Journal of Pharmaceutical Sciences 26(6): 1215-1219
Zhang, Y.-h.; Pang, H.-y.; Xiao, X.-h.; Wen, H.-x.; Ni, J. 2011: Effects of soy isoflavones and major active component genistein on the expression of ovarian estrogen receptor-α in rats Zhonghua Yi Xue Za Zhi 91(28): 1987-1991
Vasil'eva, V.N.; Dzadzieva, M.F.; Bystrova, A.N. 1993: The isolation of the biologically active component of the membrane ribosomal fraction obtained from L-transformants of Yersinia pseudotuberculosis Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 75-76
Primus, T.M.; Kohler, D.J.; Goodall, M.A.; Yoder, C.; Mathies, T.; Miller, L.; Johnston, J.J.; Vercauteren, K. 2003: Liquid chromatographic determination of 4,4'-dinitrocarbanilide, the active component of the infertility agent nicarbazin, in chicken, duck, goose, and snake eggs Journal - Association of Official Analytical Chemists 86(6): 1144-1148
Nasonov, E.L.; Burlev, V.A.; Golosova, T.V.; Speranskiĭ, A.I.; Somova, A.V. 1977: Autoimmune component in chronic active hepatitis and its connection with isolation of the hepatitis B surface antigen Terapevticheskii Arkhiv 49(6): 84-89
Oshikawa, T.; Okamoto, M.; Ahmed, S.U.; Tano, T.; Yoshida, H.; Sato, M. 2004: Anti-cancer effect of an intratumoral injection of dendritic cells expressing TLR4 in combination with an active component of OK-432 in TLR4-deficient mice Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1770-1772
Ovsiannikov, V.I.; Khashimov, K.A.; Kostko, S.Z. 1976: Effect of propranolol (obsidan) on myocardial contractility Kardiologiia 16(8): 126-127
Antiuf'ev, V.F.; Sukhanov, V.A. 1983: Action of obsidan on platelet hemostasis in patients with atrial fibrillation Klinicheskaia Meditsina 61(10): 64-67
Shikhsaidov, I.I. 1981: Effect of obsidan on blood electrolyte content in toxic goiter Problemy Endokrinologii 27(4): 3-6
Kisliak, O.A.; Storozhakov, G.I. 1984: Experience with the treatment of patients with hypertrophic cardiomyopathy with obsidan and isoptin Kardiologiia 24(8): 27-30
Thomas, H.C.; Potter, B.J.; Elias, E.; Sherlock, S. 1979: Metabolism of the third component of complement in acute type B hepatitis, HBs antigen positive glomerulonephritis, polyarteritis nodosum, and HBs antigen positive and negative chronic active liver disease Gastroenterology 76(4): 673-679
Kiseleva, Z.M.; Orlova, A.I. 1979: Study of catecholamines and DOPA in obsidan treatment of patients with circulatory insufficiency Terapevticheskii Arkhiv 51(1): 49-53
Tuganova, T.N.; Bolgova, L.S.; Alekseenko, O.I.; Makhortova, M.G. 2004: Cytological criteria for therapeutic component of pathomorphosis of epithelial component of lymphoepithelial pineal tumor Voprosy Onkologii 50(3): 327-331
Minkov, I.P. 1991: Erythrocyte membranes in patients with congenital cyanotic heart disease before and after obsidan therapy Kardiologiia 31(10): 66-68
Ianovskiĭ, G.V.; Shevchuk, S.G.; Girina, N.I.; Petrusha, G.N. 1978: Preventive treatment of ischemic heart disease with obsidan and nerobolil under ambulatory conditions Vrachebnoe Delo 1978(6): 16-18